Reconstruction conditions, dose drift, and slice thickness changes that standard metadata pipelines cannot detect materially affect what your model actually sees. GammaMetric characterizes the imaging environment your AI encounters — so you know when a study is inside or outside its validated envelope.
Sensitivity benchmarks tell you how a model performed during validation. GammaMetric tells you whether today's study resembles those validation conditions.
Every study is scored against the model's characterized acquisition envelope. Two examples — the same engine, two different protocol states.
Two independent instruments. One acquisition event. Image reliability and AI robustness scored separately — each grounded in published perturbation data.
AI vendors integrate it through a REST API or DICOM webhook — a per-scan reliability score before a result is surfaced. Health systems use it for continuous site monitoring — automated alerts when acquisition conditions drift outside the validated envelope. Same physics, same signal, different surfaces.
The gap between validation conditions and real-world deployment is where AI performance quietly degrades — and where accountability belongs to whoever ships the model.
ConvolutionKernel reads identically for FBP and iterative reconstruction on major scanners. Slice thickness varies across sites. Dose drifts without notice. Standard pipelines are blind to acquisition conditions that materially affect model performance.
FDA clearance is tested at controlled dose levels and standard protocols. Real-world sites run lower doses, thicker slices, and varied reconstruction. The gap between "cleared" and "deployed" is rarely measured — until now.
When acquisition conditions push a study outside the validated envelope, the AI result is unreliable — but the model gets blamed. GammaMetric quantifies which studies are operating outside that envelope before a result is surfaced.
GammaMetric runs passively in your pipeline. Every study gets scored before your AI result is surfaced — your system decides what to do with the signal.
Forward DICOM headers (or pixel data) to the GammaMetric API via webhook or REST. Only acquisition parameters and pixel patches are used — no PHI transmitted, no image storage.
Each study is scored against your model's characterized acquisition envelope. Slice thickness, kernel, dose, and reconstruction state are all assessed. You get a robustness score — Within Characterized Range, Review Recommended, or Outside Envelope — plus expected performance change relative to baseline.
Show the result. Suppress it. Flag it. Route it to secondary review. GammaMetric returns the signal — you own the decision. No clinical logic baked in, no radiologist-facing UI required.
Generate a site-specific reliability report from any study — acquisition profile, robustness characterization across kernel, dose, and slice thickness, and protocol observations. Suitable for post-market surveillance documentation.
Request a Demo →Self-serve CT dose monitoring at dose.gammametric.com. Leapfrog Section 8B reporting, ACR DIR benchmarking, drift alerts. Free to use.
Try It Free →Median DLP for routine head and abdomen-pelvis CT across all five Leapfrog pediatric age groups (<1, 1–4, 5–9, 10–14, 15–17) — formatted and ready for Section 8B reference.
Your facility's dose percentiles compared against ACR Dose Index Registry national reference levels. Clear status flags — Excellent, Acceptable, or Above Benchmark — for every body region.
Automatic identification of exams with unusually high DLP — repeat acquisitions, wrong protocols, or multi-phase studies — with transparent methodology notes for your physics team.
Physicist observations on protocol consistency, scanner variability, and dose reduction opportunities — useful context for your quality improvement program beyond compliance reporting.
Dose trends visualized across your full reporting period. Identify protocol changes, scanner drift, or technologist variability — supporting ongoing QA program development beyond Leapfrog season.
Publication-quality output with percentile tables, benchmark charts, methodology documentation, and your facility name — suitable for quality committee presentation or Leapfrog submission reference.
GammaMetric's own pilot study quantifies how acquisition variability affects imaging AI — and why protocol optimization matters beyond compliance.
Patients who receive a different AI-derived Lung-RADS follow-up recommendation between full-dose and quarter-dose reconstructions of the same scan (n=183, LIDC-IDRI; replicated on real projection-domain data, AAPM Mayo).
Sensitivity drop at 5mm slice thickness versus standard. The gap between your protocol and the vendor's validation conditions is rarely measured.
Domain separability between FBP and iterative reconstruction on phantom data — with identical DICOM ConvolutionKernel tags. Standard metadata pipelines cannot detect this condition. Pixel analysis can.
We're working with a small number of AI vendors and health systems to run pilots. If you're validating an AI model, deploying into multi-site environments, or building post-market surveillance infrastructure, we'd like to talk.
Characterize your model's acquisition envelope across kernel, dose, slice thickness, and vendor. Receive a physicist-reviewed report suitable for regulatory documentation. API access for per-scan scoring in production.
Request a Demo →Passive DICOM listener on one scanner. Every study scored automatically. Email alerts when acquisition conditions fall outside the validated envelope. Full audit log. No workflow change required.
Request a Pilot →15-minute call. No pitch deck — just your model, your sites, and whether GammaMetric fits.